A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women

What Was Tested

The paper reports a study of Leuprolide and Triptorelin in the context of endometriosis, published as a randomized controlled trial.

Different gonadotropin-releasing-hormone agonist (GnRH-a) formulations with different potency and associated side effects, therefore, different compliance and persistence of therapy.

This study was to evaluate the difference of hormonal profile and side effects due to hypoestrogenic status after treatment of leuprorelin and triptorelin in Chinese women with ovarian endometrioma after conservative surgical treatment.

Who Took Part

The study group was 302 women.

By PubMed's age tags, the people studied were teenagers, young adults, adults and middle-aged adults, women only.

A total of 302 women underwent laparoscopic excision of ovarian endometriomas with rASRM III and IV were enrolled in the study.Subjects were randomized into two groups with use of a random table.

Twenty two patients dropped out during the study.

How the Study Was Run

In design terms this was a randomized and single-blind study.

Random assignment meant chance, not the researchers, decided who got Leuprolide and who got the comparison, which limits bias.

In this single-blind Leuprolide study one party knew the assignments and the other did not.

Menopausal symptoms were evalutaed using a questionnaire and serum sex hormonal levels were also measured during the follow-up.

What Was Measured

The subject headings attached to it are Biomarkers, Chemotherapy, Adjuvant, China, Endometriosis, Hormone Antagonists, Hormones and Laparoscopy.

The authors tagged it with the keywords Gonadotropin-releasing hormone, Leuprorelin, Ovary endometriosis and Triptorelin.

What This Means in Plain Language

The paper is a randomized and single-blind study of Leuprolide and Triptorelin in 302 women in people with endometriosis.

With several hundred people or more, it is a fairly large study for this kind of research.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2014 (European journal of obstetrics, gynecology, and reproductive biology), a journal based in Ireland.

More context: the Leuprolide compound page and the Triptorelin compound page, Endometriosis research.